Literature DB >> 6354022

Mediator release after nasal airway challenge with allergen.

R M Naclerio, H L Meier, A Kagey-Sobotka, N F Adkinson, D A Meyers, P S Norman, L M Lichtenstein.   

Abstract

An in vivo model of human allergic disease has been developed in which nasal challenge with antigen leads to physiologic changes, together with a release of increased amounts of inflammatory mediators into nasal secretions obtained by washing the nose with saline. In 105 experiments involving 35 subjects, only allergic subjects consistently demonstrated an increase in the concentrations of the mast cell mediator, histamine, and the putative mast cell mediators, TAME-esterase and PGD2. The release of each mediator was significantly (p less than 0.001) related to the physiologic change (sneezing). The release of each mediator also correlated significantly with the release of the other 2 mediators (p less than 0.001). This system, for the first time, clearly relates an in vivo symptom and mediator release and thus should provide an excellent tool for the further study of the allergic response and nasal pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6354022     DOI: 10.1164/arrd.1983.128.4.597

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  82 in total

Review 1.  The role of leukotrienes and antileukotriene agents in the pathogenesis and treatment of allergic rhinitis.

Authors:  R A Simon
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  The use of the nose to study the inflammatory response of the respiratory tract.

Authors:  C G Persson; C Svensson; L Greiff; M Anderson; P Wollmer; U Alkner; I Erjefält
Journal:  Thorax       Date:  1992-12       Impact factor: 9.139

3.  The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling.

Authors:  Yeon Ho Choi; Sang-Nam Lee; Hiroki Aoyagi; Yasundo Yamasaki; Jung-Yoon Yoo; Boryung Park; Dong Min Shin; Ho-Geun Yoon; Joo-Heon Yoon
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

4.  Reversibility and reproducibility of histamine induced plasma leakage in nasal airways.

Authors:  C Svensson; C R Baumgarten; U Pipkorn; U Alkner; C G Persson
Journal:  Thorax       Date:  1989-01       Impact factor: 9.139

5.  Proceedings of the British Thoracic Society. 12-14 July 1989, University of Southampton. Abstracts.

Authors: 
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

6.  A study of the action of bradykinin and bradykinin analogues in the human nasal airway.

Authors:  C E Austin; J C Foreman
Journal:  J Physiol       Date:  1994-07-15       Impact factor: 5.182

7.  Immunoglobulins in nasal secretions of patients with allergic rhinitis and chronic rhinosinusitis.

Authors:  Chung-Han Hsin; Chia-Tung Shun; Chia-Ming Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-08       Impact factor: 2.503

8.  Failure of frusemide to increase production of prostaglandin E2 in human nasal mucosa in vivo.

Authors:  J Mullol; I Ramis; J Prat; J Roselló-Catafau; A Xaubet; C Piera; E Gelpí; C Picado
Journal:  Thorax       Date:  1993-03       Impact factor: 9.139

9.  Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase.

Authors:  J W Dear; S Ghali; J C Foreman
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Influx of kininogens into nasal secretions after antigen challenge of allergic individuals.

Authors:  C R Baumgarten; A G Togias; R M Naclerio; L M Lichtenstein; P S Norman; D Proud
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.